Company Info
| Year Established: | 2021 |
Contacts
| Primary: | Stanley Lewis M.D., M.P.H. Founder & CEO |
| Other: | Tom Kottler Co-Founder, President & COO Carola Leuschner, Ph.D. VP, R&D |
Company Description
A28 Therapeutics is a privately-held, clinical-stage biopharmaceutical company focused on the development of its targeted lytic peptide platform for the treatment of multiple cancer types.
